State Street’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.76M Sell
1,943,690
-1,761,771
-48% -$4.32M ﹤0.01% 2964
2025
Q1
$24.7M Buy
3,705,461
+247,382
+7% +$1.65M ﹤0.01% 2007
2024
Q4
$43.5M Buy
3,458,079
+356,057
+11% +$4.48M ﹤0.01% 1790
2024
Q3
$57.3M Buy
3,102,022
+322,156
+12% +$5.95M ﹤0.01% 1633
2024
Q2
$59.9M Sell
2,779,866
-1,413,211
-34% -$30.4M ﹤0.01% 1573
2024
Q1
$113M Buy
4,193,077
+961,666
+30% +$25.9M 0.01% 1225
2023
Q4
$96.8M Buy
3,231,411
+91,906
+3% +$2.75M ﹤0.01% 1306
2023
Q3
$64.3M Sell
3,139,505
-39,019
-1% -$799K ﹤0.01% 1466
2023
Q2
$63.2M Sell
3,178,524
-841,162
-21% -$16.7M ﹤0.01% 1516
2023
Q1
$68.9M Buy
4,019,686
+40,701
+1% +$697K ﹤0.01% 1432
2022
Q4
$77.9M Buy
3,978,985
+586,652
+17% +$11.5M ﹤0.01% 1344
2022
Q3
$54.1M Buy
3,392,333
+856,076
+34% +$13.7M ﹤0.01% 1540
2022
Q2
$34.9M Sell
2,536,257
-217,390
-8% -$2.99M ﹤0.01% 1875
2022
Q1
$43.7M Buy
2,753,647
+410,234
+18% +$6.51M ﹤0.01% 1853
2021
Q4
$51.2M Buy
2,343,413
+3,479
+0.1% +$75.9K ﹤0.01% 1792
2021
Q3
$69.9M Buy
2,339,934
+579,034
+33% +$17.3M ﹤0.01% 1553
2021
Q2
$78M Buy
1,760,900
+147,812
+9% +$6.55M ﹤0.01% 1505
2021
Q1
$71.6M Buy
1,613,088
+457,043
+40% +$20.3M ﹤0.01% 1479
2020
Q4
$63.4M Sell
1,156,045
-477,010
-29% -$26.2M ﹤0.01% 1485
2020
Q3
$37.3M Buy
1,633,055
+44,666
+3% +$1.02M ﹤0.01% 1658
2020
Q2
$33.2M Buy
1,588,389
+622,674
+64% +$13M ﹤0.01% 1707
2020
Q1
$13.5M Buy
965,715
+56,153
+6% +$783K ﹤0.01% 2079
2019
Q4
$20.7M Sell
909,562
-67,311
-7% -$1.53M ﹤0.01% 2111
2019
Q3
$11.4M Sell
976,873
-109,999
-10% -$1.28M ﹤0.01% 2413
2019
Q2
$16.3M Buy
1,086,872
+234,299
+27% +$3.51M ﹤0.01% 2239
2019
Q1
$15M Buy
852,573
+470,731
+123% +$8.26M ﹤0.01% 2245
2018
Q4
$5.66M Buy
381,842
+9,108
+2% +$135K ﹤0.01% 2661
2018
Q3
$9.17M Buy
372,734
+12,842
+4% +$316K ﹤0.01% 2589
2018
Q2
$7.07M Buy
+359,892
New +$7.07M ﹤0.01% 2696
2017
Q3
Sell
-3,675
Closed -$27K 3765
2017
Q2
$27K Sell
3,675
-63,114
-94% -$464K ﹤0.01% 3638
2017
Q1
$533K Buy
66,789
+406
+0.6% +$3.24K ﹤0.01% 3374
2016
Q4
$1.62M Buy
66,383
+2,236
+3% +$54.5K ﹤0.01% 3167
2016
Q3
$2.43M Buy
64,147
+1,033
+2% +$39.1K ﹤0.01% 2904
2016
Q2
$1.88M Buy
+63,114
New +$1.88M ﹤0.01% 3056